FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy

MLA

Maria Romano, et al. FKBP51s Signature in Peripheral Blood Mononuclear Cells of Melanoma Patients as a Possible Predictive Factor for Immunotherapy. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8ac1f6e1e8b131d3184796be992abff2&authtype=sso&custid=ns315887.

APA

Maria Romano, Vito Alessandro Lasorsa, Anna D’Angelillo, Simona Romano, Michele Russo, Nicola Zambrano, Mario Capasso, Paolo A. Ascierto, Ester Simeone, & Paolo D’Arrigo. (2017). FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy.

Chicago

Maria Romano, Vito Alessandro Lasorsa, Anna D’Angelillo, Simona Romano, Michele Russo, Nicola Zambrano, Mario Capasso, Paolo A. Ascierto, Ester Simeone, and Paolo D’Arrigo. 2017. “FKBP51s Signature in Peripheral Blood Mononuclear Cells of Melanoma Patients as a Possible Predictive Factor for Immunotherapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8ac1f6e1e8b131d3184796be992abff2&authtype=sso&custid=ns315887.